Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Deferasirox Fe3+ Chelate (A3355): Reliable Iron Chelation in
2026-05-28
This article explores real-world research challenges in iron overload and cell-based assays, demonstrating how Deferasirox Fe3+ chelate (SKU A3355) provides reproducible, high-purity solutions. Drawing on workflow scenarios and peer-reviewed references, we clarify its advantages in protocol optimization, data interpretation, and vendor selection for sensitive iron chelation studies.
-
Transcription Condensate Dynamics Safeguard Genome Stability
2026-05-28
Marmolejo et al. uncover how precise formation and dissolution of transcription condensates at histone locus bodies (HLBs) coordinate histone gene expression with DNA replication during S phase. Their findings reveal a kinase-regulated mechanism that prevents genome instability by balancing linker histone production, offering new perspectives for cancer research and chromatin biology.
-
UGDH Phosphorylation Drives Glycosaminoglycan Synthesis and
2026-05-27
This study reveals that phosphorylation of UDP-glucose dehydrogenase (UGDH) at serine 316 promotes glycosaminoglycan biosynthesis, enhancing prostate cancer cell motility, spheroid growth, and resistance to Enzalutamide. These findings highlight a novel metabolic mechanism underlying castration-resistant prostate cancer and suggest new targets for therapeutic intervention.
-
Generation of iPSC Lines for Mood Disorder Mechanism Studies
2026-05-27
The reference study details the derivation and validation of two induced pluripotent stem cell (iPSC) lines from a mother–child pair with major depressive disorder and bipolar disorder. These lines provide a genetically controlled platform for dissecting psychiatric disease mechanisms and enable future research into targeted therapies and shared molecular pathways.
-
Octanoic Acid Modulates Macrophage Polarization via PPARγ in
2026-05-26
This study demonstrates that octanoic acid-rich enteral nutrition alleviates inflammatory bowel disease by regulating intestinal macrophage polarization through the PPARγ/STAT-1/STAT-6 pathway. The findings highlight a defined immunometabolic mechanism and provide a foundation for targeted nutritional and pharmacological interventions in chronic intestinal inflammation.
-
Dynamic Remodeling of CNS Myelin Sheaths After Damage
2026-05-26
Arafa et al. demonstrate that myelin sheaths in the central nervous system can dynamically remodel and recover from early swelling damage, challenging the prevailing view that myelin loss is inevitable after injury. Their findings redefine the mechanistic understanding of demyelination and highlight neuronal activity as a modifiable factor in early myelin pathology.
-
SARS-CoV-2 N Protein Suppresses GADD34-Driven Innate Immunit
2026-05-25
This study reveals a novel immune evasion mechanism by which the SARS-CoV-2 nucleocapsid protein antagonizes the GADD34-mediated innate immune pathway. By inducing atypical stress granule-like foci and sequestering GADD34 mRNA, SARS-CoV-2 impairs IRF3 nuclear translocation and interferon signaling, highlighting new targets for antiviral research.
-
Mechanistic Insights into Gepotidacin and DNA Gyrase Inhibit
2026-05-25
This article reviews Gibson et al.'s structural and mechanistic analysis of gepotidacin, a novel bacterial topoisomerase inhibitor targeting Staphylococcus aureus gyrase. The study's findings clarify how gepotidacin acts distinctly from fluoroquinolones, shaping future antibiotic research and resistance mitigation strategies.
-
Direct Mouse Genotyping Kit: Accelerate PCR from Mouse Tissu
2026-05-24
The Direct Mouse Genotyping Kit streamlines PCR workflows by enabling rapid, purification-free DNA extraction directly from mouse tissue. With its optimized lysis buffer and ready-to-use PCR master mix with dye, this APExBIO solution empowers high-throughput, reliable genotyping for demanding biomedical research applications.
-
Deferasirox Fe3+ Chelate: Precision Tools for Iron Overload
2026-05-23
Deferasirox Fe3+ chelate empowers researchers to dissect iron metabolism and cell death pathways in chronic anemia and beta-thalassemia models. This guide details robust protocols, troubleshooting strategies, and new experimental frontiers, translating the latest mechanistic findings into actionable workflows.
-
Gap19: Selective Connexin 43 Hemichannel Blocker in Neuropro
2026-05-22
Gap19 stands out as a selective connexin 43 hemichannel blocker, enabling targeted neuroglial and immune modulation without impacting gap junctions. Its robust solubility and workflow-ready formulation from APExBIO accelerate advanced research in cerebral ischemia and inflammation.
-
Berbamine Hydrochloride: NF-κB Inhibition and Ferroptosis in
2026-05-22
This article provides translational researchers with a forward-thinking roadmap for leveraging Berbamine hydrochloride in the study of hepatocellular carcinoma (HCC) and ferroptosis resistance. By integrating mechanistic insights into NF-κB signaling and the METTL16-SENP3-LTF axis, alongside practical protocol guidance and a competitive landscape analysis, we highlight Berbamine hydrochloride’s unique value in cancer research. The content distinguishes itself by connecting recent advances in RNA methylation-driven ferroptosis resistance with actionable strategies for experimental design, moving beyond standard product summaries and offering a future-facing perspective.
-
Acetylcholine Chloride in Cholinergic Signaling Research
2026-05-21
Acetylcholine Chloride (B1596) from APExBIO delivers unmatched reliability for dissecting cholinergic signaling in complex, translational neuroscience assays. This guide details hands-on protocols, troubleshooting, and new experimental insights derived from gut-brain axis research.
-
4-Ethylphenyl Sulfate in Gut-Brain and Renal Biomarker Workf
2026-05-21
4-Ethylphenyl sulfate stands at the intersection of gut-brain axis and renal disease research, enabling precise behavioral, biomarker, and adsorption assays. This article guides researchers through advanced workflows, protocol parameters, and troubleshooting—bridging fundamental findings with real-world experimental success.
-
PDK4-IN-1 Hydrochloride: Precision Control of PDH and Mitoch
2026-05-20
Explore the advanced applications of PDK4-IN-1 hydrochloride as a pyruvate dehydrogenase kinase 4 inhibitor. This article delivers unique scientific insights into PDH activation, in vivo and in vitro workflow design, and metabolic disease research.